Search clinical trials for: Tacrolimus ointment

Total 1782 results

Hospital Universitario Dr. Jose E. Gonzalez

Recruiting

Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT

Ocular Graft-versus-host Disease

Mexico
Vanderbilt University Medical Center

Recruiting

Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns

Burn Injury

United States
Tanta University

Recruiting

A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone

Dermatologic Disease

Egypt
West China Hospital

Recruiting

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma

China
Clarteis

Completed

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

Autoimmune Diseases | Pediatric ALL | Vitiligo | Dermatologic Disease

Jordan
Chang Gung Memorial Hospital
Ministry of Science and Technology, Taiwan

Completed

Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis

Atopic Dermatitis

Taiwan
University of Rochester

Completed

ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis

Atopic Dermatitis

United States
Combined Military Hospital Abbottabad

Completed

Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo

Vitiligo

Pakistan
Jordan University of Science and Technology

Active, not recruiting

Phototherapy Combination With Topicals in Vitiligo (NBUVB)

Vitiligo, Generalized

Jordan
Odense University Hospital

Completed

Tacrolimus as Treatment of Breast Cancer-Related Lymphedema

Breast Cancer Lymphedema

Denmark
Assiut University

Completed

Uses of Tacrolimus in Behcet Disease

Behcet Syndrome | Oral Ulcer

Egypt
Odense University Hospital

Active, not recruiting

Prevention of Breast Cancer-related Lymphedma With Tacrolimus (BCRL-TACRO)

Lymphedema

Denmark
Jacob Thyssen
LEO Pharma

Completed

The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover

Atopic Dermatitis | Atopic Eczema

Denmark
Hospices Civils de Lyon

Completed

Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT) (TACRO)

Hemorrhagic Hereditary Telangiectasia (HHT)

France
Benha University

Completed

Corneal Densitometry Changes With Adenoviral SEI

Corneal Disease

United Arab Emirates
LEO Pharma

Terminated

A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis (APPLES)

Atopic Dermatitis

United States, Netherlands, United Kingdom, France, Canada, Ireland, Austria, Germany, Poland
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)

Atopic Dermatitis

United States
Pfizer

Completed

A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test

Psoriasis

Germany
University of British Columbia

Unknown

Tacrolimus for Malar Edema

Edema Face

Canada
Wake Forest University

Completed

Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit

Atopic Dermatitis

United States
National Taiwan University Hospital

Unknown

Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis

Tacrolimus | Vernal Keratoconjunctivitis | Atopic Keratoconjunctivitis

Taiwan
University Hospital, Rouen

Completed

Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis (Disease)

Severe Seborrheic Dermatitis

France
Sohag University

Unknown

Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo

Vitiligo | Tacrolimus

Egypt
Assiut University

Unknown

The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo

Vitiligo Vulgaris
Ajou University School of Medicine

Completed

Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo

Vitiligo | Dermatologic Disease

Korea, Republic of
University of Oulu
Kuopio University Hospital

Terminated

Tacrolimus Ointment in Oral Lichen Planus

Oral Lichen Planus

Finland
University of California, Davis

Withdrawn

Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis

Atopic Dermatitis
Fougera Pharmaceuticals Inc.

Completed

Study of 0417 Ointment in the Treatment of Atopic Dermatitis

Atopic Dermatitis

United States
Fougera Pharmaceuticals Inc.

Completed

Study of 0416 Ointment in the Treatment of Atopic Dermatitis

Atopic Dermatitis

United States
Astellas Pharma Inc

Completed

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

Dermatitis, Atopic

United States
Astellas Pharma Inc

Completed

Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

Dermatitis

United States
Astellas Pharma Inc

Completed

Long-term Safety of Protopic in Atopic Eczema

Dermatitis, Atopic | Eczema, Atopic

France, Germany, United Kingdom, Spain, Belgium, Netherlands, Finland, Poland, Ireland, Hungary, Denmark, Latvia
Astellas Pharma Inc

Completed

Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis

Atopic Dermatitis

Australia, Belgium, Poland, Hungary, Portugal, Germany, Iceland, Malta
Astellas Pharma Inc

Completed

A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

Dermatitis, Atopic

United States, Canada
Astellas Pharma Inc

Completed

Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment

Dermatitis, Atopic

France, Germany, Spain, Belgium, Netherlands, Finland, Austria, United Kingdom, Italy, Czech Republic, Switzerland, Portugal, Denmark
Astellas Pharma Inc

Completed

A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis

Dermatitis, Atopic

United States
Astellas Pharma Inc

Completed

Distribution of Tacrolimus in Skin, Atopic Dermatitis

Dermatitis, Atopic

Ireland
Astellas Pharma Inc

Completed

Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

Dermatitis, Atopic

France, United Kingdom, Spain, Belgium, Portugal, Netherlands, Finland, Czech Republic, Germany, Hungary, Italy
Astellas Pharma Inc

Completed

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis

Dermatitis, Atopic

United States
Centre Hospitalier Universitaire de Nice

Terminated

Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control

Pigmentation Disorders | Vitiligo

France
Astellas Pharma Inc

Completed

Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis

Dermatitis, Atopic

United Kingdom, Finland, Ireland, Canada, Latvia
Astellas Pharma Inc

Completed

Protopic Ointment in Children Atopic Eczema

Dermatitis, Atopic

France
Astellas Pharma Inc

Completed

Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

Italy
Astellas Pharma Inc

Completed

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

Dermatitis, Atopic

Poland, Czech Republic, Hungary
Astellas Pharma Inc

Completed

Protopic Ointment in Adult Atopic Eczema of the Face

Dermatitis, Atopic

France
Astellas Pharma Inc

Completed

Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis

Dermatitis, Atopic

United Kingdom, Finland, Ireland, Canada, Latvia
Astellas Pharma Inc

Completed

Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

Italy
Astellas Pharma China, Inc.

Completed

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

Moderate/Severe Atopic Dermatitis

China
Taro Pharmaceuticals USA

Completed

Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis

Atopic Dermatitis
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Atopic Dermatitis

United States

3

Subscribe